John J. Kiely's most recent trade in Amneal Pharmaceuticals Inc - Ordinary Shares - Class A was a trade of 32,000 Class A Common Stock done at an average price of $9.2 . Disclosure was reported to the exchange on Aug. 27, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Amneal Pharmaceuticals Inc | John J. Kiely | Director | Sale of securities on an exchange or to another person at price $ 9.23 per share. | 27 Aug 2025 | 32,000 | 225,433 (0%) | 0% | 9.2 | 295,360 | Class A Common Stock |
| Amneal Pharmaceuticals Inc | John J. Kiely | Director | Sale of securities on an exchange or to another person at price $ 7.59 per share. | 12 May 2025 | 50,000 | 257,433 (0%) | 0% | 7.6 | 379,500 | Class A Common Stock |
| Amneal Pharmaceuticals Inc | John J. Kiely | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2025 | 40,258 | 307,433 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc | John J. Kiely | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2025 | 40,258 | 0 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc | John J. Kiely | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2025 | 34,819 | 34,819 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc | John J. Kiely | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Nov 2024 | 28,506 | 0 | - | - | Stock Option | |
| Amneal Pharmaceuticals Inc | John J. Kiely | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.76 per share. | 22 Nov 2024 | 28,506 | 284,233 (0%) | 0% | 4.8 | 135,689 | Class A Common Stock |
| Amneal Pharmaceuticals Inc | John J. Kiely | Director | Sale of securities on an exchange or to another person at price $ 8.38 per share. | 22 Nov 2024 | 17,058 | 267,175 (0%) | 0% | 8.4 | 142,946 | Class A Common Stock |
| Amneal Pharmaceuticals Inc | John J. Kiely | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2024 | 76,453 | 255,727 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc | John J. Kiely | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2024 | 76,453 | 0 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc | John J. Kiely | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2024 | 40,258 | 40,258 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc | John J. Kiely | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2023 | 80,128 | 0 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc | John J. Kiely | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2023 | 80,128 | 179,274 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc | John J. Kiely | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2023 | 76,453 | 76,453 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc | John J. Kiely | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2022 | 80,128 | 80,128 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc | John J. Kiely | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2022 | 35,406 | 99,146 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc | John J. Kiely | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2022 | 35,406 | 0 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc | John J. Kiely | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2021 | 46,218 | 0 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc | John J. Kiely | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2021 | 46,218 | 63,740 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc | John J. Kiely | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2021 | 35,406 | 35,406 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc | John J. Kiely | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2020 | 7,522 | 0 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc | John J. Kiely | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2020 | 7,522 | 17,522 (0%) | 0% | - | Class A Common Stock |